iBio, Inc. Common Stock (IBIO) Stock Analysis

iBio, Inc. Common Stock (IBIO) is a publicly traded company in the HEALTHCARE sector. It trades at $1.76, carries a market capitalization of $93.89M. This page summarizes the public market data, fundamentals, and frequently asked questions for IBIO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $1.76
• Market Cap: $93.89M
• EPS: $-0.56
• 52-Week High: $3.82
• 52-Week Low: $0.56

Market Sentiment

iBio, Inc. Common Stock currently has a Bullish sentiment score of 0.40.

About iBio, Inc. Common Stock

iBio, Inc. is a pioneering biotechnology firm specializing in plant-based biopharmaceutical production, headquartered in New York. The company offers contract development and manufacturing services for biologics, focusing on vaccines and therapeutics, thereby serving as a vital partner for organizations in the United States and internationally. With its proprietary technologies, iBio is dedicated to improving efficiency and scalability in the biologics manufacturing process, addressing the in...

GNG Research Analysis

GNG Research scores iBio, Inc. Common Stock (IBIO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for IBIO.

Frequently Asked Questions

Does IBIO pay dividends?

iBio, Inc. Common Stock (IBIO) does not currently pay a regular dividend.

What is IBIO's market cap?

iBio, Inc. Common Stock (IBIO) has a market capitalization of $93.89M with a current stock price of $1.76.